Novo Nordisk attempts to acquire weight-loss drug company Metsera during government shutdown, potentially avoiding FTC antitrust review and regulatory scrutiny.

Pfizer has filed a lawsuit against Metsera and Novo Nordisk, saying Metsera breached its merger agreement obligations.

Pfizer must convince Delaware courts that Novo, already dominant in GLP-1 treatments with Wegovy and Ozempic ... The post ...

Eli Lilly is partnering with Walmart to offer Zepbound through its direct-to-consumer program, making the popular medication ...

Here are some companies that have moved to cut jobs recently. General Motors moved to lay off about 1,700 workers across ...

Email: [email protected] Jeremy Clarkson, yet again, appears to be having problems with his trousers falling down after making the switch to weight-loss drugs. The Grand Tour presenter, 65, underwent ...

It's a tough time for the job market. Amid wider economic uncertainty, some analysts have said that businesses are at a ...

New Scripps Research trial will explore the effects of Lilly’s GLP-1 drug on reducing the symptoms of the debilitating disease.

Pfizer is suing over some unsolicited competition in its nearly $5 billion bid to buy the drugmaker Metsera. New York-based Pfizer said Friday after markets closed that it was suing Metsera and a ...

Up to 5,000 people in Scotland will take the injections as part of a multi-million pound study being led by Glasgow University.

With a new generation of weight-loss drugs entering Indian markets, spelling hope for many, The Indian Express tracks the ...